Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice
- PMID: 12552113
- PMCID: PMC298791
- DOI: 10.1073/pnas.0237106100
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice
Abstract
Glucagon, the counter-regulatory hormone to insulin, is secreted from pancreatic alpha cells in response to low blood glucose. To examine the role of glucagon in glucose homeostasis, mice were generated with a null mutation of the glucagon receptor (Gcgr(-/-)). These mice display lower blood glucose levels throughout the day and improved glucose tolerance but similar insulin levels compared with control animals. Gcgr(-/-) mice displayed supraphysiological glucagon levels associated with postnatal enlargement of the pancreas and hyperplasia of islets due predominantly to alpha cell, and to a lesser extent, delta cell proliferation. In addition, increased proglucagon expression and processing resulted in increased pancreatic glucogen-like peptide 1 (GLP-1) (1-37) and GLP-1 amide (1-36 amide) content and a 3- to 10-fold increase in circulating GLP-1 amide. Gcgr(-/-) mice also displayed reduced adiposity and leptin levels but normal body weight, food intake, and energy expenditure. These data indicate that glucagon is essential for maintenance of normal glycemia and postnatal regulation of islet and alpha and delta cell numbers. Furthermore, the lean phenotype of Gcgr(-/-) mice suggests glucagon action may be involved in the regulation of whole body composition.
Figures





Similar articles
-
Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.Gastroenterology. 2010 Sep;139(3):857-68. doi: 10.1053/j.gastro.2010.05.006. Epub 2010 Jun 11. Gastroenterology. 2010. PMID: 20546737
-
Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.Diabetes. 2013 Apr;62(4):1196-205. doi: 10.2337/db11-1605. Epub 2012 Nov 16. Diabetes. 2013. PMID: 23160527 Free PMC article.
-
Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E624-32. doi: 10.1152/ajpendo.00102.2010. Epub 2010 Jul 20. Am J Physiol Endocrinol Metab. 2010. PMID: 20647556
-
Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.Horm Metab Res. 2004 Nov-Dec;36(11-12):766-70. doi: 10.1055/s-2004-826161. Horm Metab Res. 2004. PMID: 15655706 Review.
-
Metabolic impact of glucagon deficiency.Diabetes Obes Metab. 2011 Oct;13 Suppl 1:151-7. doi: 10.1111/j.1463-1326.2011.01456.x. Diabetes Obes Metab. 2011. PMID: 21824269 Review.
Cited by
-
Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism.PLoS One. 2012;7(11):e50629. doi: 10.1371/journal.pone.0050629. Epub 2012 Nov 29. PLoS One. 2012. PMID: 23209793 Free PMC article.
-
Delineating the activation mechanism and conformational landscape of a class B G protein-coupled receptor glucagon receptor.Comput Struct Biotechnol J. 2022 Jan 20;20:628-639. doi: 10.1016/j.csbj.2022.01.015. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35140883 Free PMC article.
-
The glutamate receptor GluK2 contributes to the regulation of glucose homeostasis and its deterioration during aging.Mol Metab. 2019 Dec;30:152-160. doi: 10.1016/j.molmet.2019.09.011. Epub 2019 Oct 1. Mol Metab. 2019. PMID: 31767166 Free PMC article.
-
Cellular Autophagy in α Cells Plays a Role in the Maintenance of Islet Architecture.J Endocr Soc. 2019 Aug 8;3(11):1979-1992. doi: 10.1210/js.2019-00075. eCollection 2019 Nov 1. J Endocr Soc. 2019. PMID: 31620668 Free PMC article.
-
LRP6 mediates cAMP generation by G protein-coupled receptors through regulating the membrane targeting of Gα(s).Sci Signal. 2011 Mar 15;4(164):ra15. doi: 10.1126/scisignal.2001464. Sci Signal. 2011. PMID: 21406690 Free PMC article.
References
-
- Burcelin R, Katz E B, Charron M J. Diabetes Metab. 1996;22:373–396. - PubMed
-
- Lefèbvre P J. Diabetes Care. 1995;18:715–730. - PubMed
-
- Kieffer T J, Habener J F. Endocr Rev. 1999;20:876–913. - PubMed
-
- Porte D, Jr, Seeley R J, Woods S C, Baskin D G, Figlewicz D P, Schwartz M W. Diabetologia. 1998;41:863–881. - PubMed
-
- Holst J J. Regul Pept. 2000;93:45–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases